Covalon Technologies Ltd. Total Assets
Covalon Technologies Ltd. total assets. Based on the latest financial reports, Covalon Technologies Ltd. (COV) holds total assets worth CA$32.80 Million CAD (≈ $23.73 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Covalon Technologies Ltd. (COV) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Covalon Technologies Ltd. (2005–2025)
Total assets of Covalon Technologies Ltd. from 2005 to 2025. This chart illustrates how Covalon Technologies Ltd.'s total assets have evolved over time, based on quarterly financial data. See Covalon Technologies Ltd. share price for real-time trading data and today's change.
Covalon Technologies Ltd. - Asset Composition Analysis
Covalon Technologies Ltd. Total Assets Breakdown (September 2025)
Covalon Technologies Ltd. total assets breakdown as of September 2025. Covalon Technologies Ltd.'s total assets of CA$32.80 Million consist of 87.3% current assets and 12.7% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 48.1% |
| Accounts Receivable | CA$5.84 Million | 16.2% |
| Inventory | CA$7.40 Million | 20.5% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$1.35 Million | 3.7% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2005–2025)
This chart illustrates how Covalon Technologies Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Covalon Technologies Ltd. (COV) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Covalon Technologies Ltd.'s current assets represent 87.3% of total assets in 2025, an increase from 26.0% in 2005.
- Cash Position: Cash and equivalents constituted 48.1% of total assets in 2025, up from 14.3% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is inventory at 20.5% of total assets.
Covalon Technologies Ltd. Competitors by Total Assets
Key competitors of Covalon Technologies Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SARTORIUS (UNSP.ADS)/1/5
F:SRT0
|
Germany | €9.87 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥11.33 Billion |
|
Guangzhou Improve Med Instrument
SHE:300030
|
China | CN¥1.02 Billion |
|
Medeon Biodesign
TWO:6499
|
Taiwan | NT$1.55 Billion |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.39 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
Covalon Technologies Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.69 | 8.12 | 0.67 |
| Quick Ratio | 4.29 | 5.94 | 0.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$22.87 Million | CA$28.10 Million | CA$-7.43 Million |
Covalon Technologies Ltd. - Advanced Valuation Insights
This section examines the relationship between Covalon Technologies Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.04 |
| Latest Market Cap to Assets Ratio | 1.49 |
| Asset Growth Rate (YoY) | 13.6% |
| Total Assets | CA$36.12 Million |
| Market Capitalization | $53.86 Million USD |
Valuation Analysis
Above Book Valuation: The market values Covalon Technologies Ltd.'s assets above their book value (1.49x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Covalon Technologies Ltd.'s assets grew by 13.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Covalon Technologies Ltd. (2005–2025)
The table below shows the annual total assets of Covalon Technologies Ltd. from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | CA$36.12 Million ≈ $26.13 Million |
+13.57% |
| 2024-09-30 | CA$31.81 Million ≈ $23.01 Million |
+27.73% |
| 2023-09-30 | CA$24.90 Million ≈ $18.01 Million |
-18.03% |
| 2022-09-30 | CA$30.38 Million ≈ $21.98 Million |
-25.14% |
| 2021-09-30 | CA$40.58 Million ≈ $29.36 Million |
+16.96% |
| 2020-09-30 | CA$34.70 Million ≈ $25.10 Million |
-12.40% |
| 2019-09-30 | CA$39.61 Million ≈ $28.65 Million |
+100.97% |
| 2018-09-30 | CA$19.71 Million ≈ $14.26 Million |
+64.68% |
| 2017-09-30 | CA$11.97 Million ≈ $8.66 Million |
+84.43% |
| 2016-09-30 | CA$6.49 Million ≈ $4.69 Million |
-14.96% |
| 2015-09-30 | CA$7.63 Million ≈ $5.52 Million |
-4.15% |
| 2014-09-30 | CA$7.96 Million ≈ $5.76 Million |
+40.41% |
| 2013-09-30 | CA$5.67 Million ≈ $4.10 Million |
-4.92% |
| 2012-09-30 | CA$5.96 Million ≈ $4.31 Million |
-36.03% |
| 2011-09-30 | CA$9.32 Million ≈ $6.74 Million |
-9.67% |
| 2010-09-30 | CA$10.32 Million ≈ $7.47 Million |
-19.80% |
| 2009-09-30 | CA$12.87 Million ≈ $9.31 Million |
-25.59% |
| 2008-09-30 | CA$17.29 Million ≈ $12.51 Million |
-14.58% |
| 2007-09-30 | CA$20.24 Million ≈ $14.64 Million |
+130.22% |
| 2006-09-30 | CA$8.79 Million ≈ $6.36 Million |
+95.39% |
| 2005-09-30 | CA$4.50 Million ≈ $3.26 Million |
-- |
About Covalon Technologies Ltd.
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more